NRPE
CAS: 30576-47-7
Ref. 3D-FN26484
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued |
Product Information
- (all-E)-1,2-Di-2-palmitin
NRPE is a recombinant protein that is synthesized in a polymeric matrix. It has been shown to have high energy efficiency, which may be due to its ability to bind metal ions and chelate them. NRPE also has been shown to have the ability to decrease the severity of eye disorders and has low energy requirements. NRPE has been shown to have pharmacological effects, including the prevention of brain infarction in rats and decreasing atp-binding cassette transporter levels in diabetic patients. This drug is a synthetic pathway for ATP synthesis that can be used as an alternative energy source. NRPE may also be used as a pharmaceutical dosage for various degenerative diseases, such as Parkinson's disease and Alzheimer's disease, or for diabetic patients.
